Key result
Smoking is linked to ~2.4 mm/decade faster sinus of Valsalva dilatation under AI surveillance.
Why the study?
The study aimed to use clinical AI to retrospectively analyze a decade of echocardiographic surveillance data to derive the rate of progression of aortic root dimensions and identify modifiers of progression.
Cohort (n=388)
Yes
Automated AI analysis of a decade of echocardiographic surveillance shows that aortic root dilatation progresses very slowly (<0.7 mm/decade on average), suggesting that annual or biennial imaging follow-up may be an inefficient use of clinical resources even in patients with risk factors like smoking or diabetes.
Answers are grounded in this paper and cite their sources.
Slow progression may support less frequent surveillance imaging; leaves open optimal intervals for smokers.
Purpose Use clinical AI to retrospectively analyze a decade of surveillance data to derive the rate of progression of aortic root dimensions and identify modifiers of progression. Methods From a multi-hospital clinical echocardiographic database covering three surveillance clinics, patients were included if they had three or more echocardiograms over >1 year within the surveillance programme. The echocardiograms were analysed using a clinical AI platform without human intervention. Associated risk factors (smoking, diabetes, hypertension, hyperlipidaemia, use of statins, beta-blockers, or ACE inhibitors / angiotensin receptor blockers) were also collected. Progression, and the impact of cardiovascular risk factors were quantified using mixed-effects modelling and deriving marginal means. Results 388 patients met the inclusion criteria, with 2374 echocardiograms over 13 years undergoing surveillance for aortic dilatation. Over 10 years, on average, there was only a slow increase in the average aortic dimensions: SoV 0.66 mm/decade, 95% CI 0.08 to 1.25; aortic annulus -0.09 mm/decade, 95% CI -0.49 to 0.30cm ; STJ 0.27 mm/decade, 95% CI -0.37 to 0.90; proximal ascending aorta 0.55 mm/decade 95% CI -0.19 to 1.30 (Figure 1). For most risk factors on most parts of the aorta, the impact on the rate of progression was small (<0.2mm/decade) and did not reach statistical significance (Figure 2). Smoking however was associated with accelerated progression at the sinus of Valsalva (2.43 mm/decade, 95% CI 1.04–3.83, p=0.001) and sinotubular junction (1.58 mm/decade, 95% CI 0.09–3.08, p=0.038). Hyperlipidaemia was associated with reduced progression at the ascending aorta (−2.21 mm/decade, 95% CI −3.72 to −0.69, p=0.004), the sinotubular junction (−1.59 mm/decade, 95% CI −2.87 to −0.31, p=0.015), and the sinus of Valsalva (−1.36 mm/decade, 95% CI −2.55 to −0.16, p=0.026). Diabetes was associated with accelerated progression at the aortic valve annulus of (1.87 mm/decade, 95% CI 0.83 to 2.90, p=0.0004). Conclusion In a retrospective analysis, harnessing automated AI measurements of surveillance data spanning a decade, progression of aortic dilatation is slow (<0.7mm/decade). Therefore, yearly or even alternate year follow-up may not be an efficient use of resources. Smoking and diabetes were identified as a significant risk factor for increased rate of dilatation, but the increase was < 2mm/decade.
No takes yet. Share an insight, caveat, or question.
Ng et al. (2026) conducted a cohort in Aortic dilatation (n=388). Cardiovascular risk factors (smoking, diabetes, hypertension, hyperlipidaemia, medications) and AI echocardiographic analysis vs. Absence of risk factors was evaluated on Rate of progression of aortic root dimensions (mm/decade) (SoV progression 0.66 mm/decade; smoking on SoV 2.43 mm/decade, 95% CI 0.08 to 1.25 (overall SoV); 1.04-3.83 (smoking on SoV), p=0.001 (for smoking on SoV)). AI surveillance showed slow overall aortic dilatation, while smoking accelerated sinus of Valsalva progression by 2.43 mm/decade.
Synapse has enriched 10 related papers. Consider them for comparative context: